GlassScriptPhysician profile
Iola Pustelnick
NPI 1275566556
$696.90
in general payments reported to CMS, 2019-2025
14 companies · $220 in 2025
The $220 reported for 2025 was more than what 82% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.23 · 2022: $165 · 2023: $213 · 2024: $53.04 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $189.44 | 2021-2023 | |
| Novo Nordisk INC | $110.84 | 2023 | Wegovy |
| Astellas Pharma US INC | $71.93 | 2023-2025 | Veozah |
| Biogen, INC. | $56.73 | 2025 | Zurzuvae |
| Organon LLC | $47.32 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $44.96 | 2024-2025 | Aptima |
| Agile Therapeutics, INC. | $38.28 | 2022 | |
| Millicent US INC | $25.74 | 2025 | Intrarosa |
| Exact Sciences Corporation | $22.75 | 2025 | The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $20.38 | 2022 | |
| Mayne Pharma Commercial LLC | $20.35 | 2022 | |
| Coopersurgical, INC. | $18.75 | 2025 | Paragard T 380a |
| Exeltis, USA INC. | $14.99 | 2025 | Slynd |
| Myovant Sciences INC. | $14.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iola Pustelnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.